The Council for Responsible Nutrition (CRN) has announced that David Campbell, vice president, North America (NA) regulatory affairs and policy, RB Health, has been elected chair of the association’s Board of Directors. Campbell served on CRN’s Executive Committee for the past two years. He will hold the chairman position through 2020, succeeding Jim Hyde, vice president and general manager at Balchem Human Nutrition and Pharma. Hyde will continue to serve on the Board as immediate past chair.

Campbell has more than 20 years of experience in the health industry. He previously served as the senior director, NA regional regulatory lead for Pfizer Consumer Health. In his role, he was responsible for leading the NA Regulatory Affairs department in the development and execution of regulatory strategies for OTC drugs, medical devices, dietary supplements and cosmetics for the U.S. and Canadian markets. Prior to that, Campbell held a variety of positions at large and mid-sized health care companies including Sanofi-Aventis, Daiichi Medical Research, Altana Pharma and Watson Pharma.

For a full list of 2019 CRN Board of Directors, visit www.crnusa.org.